These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24603852)

  • 1. Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery.
    Popat A; Jambhrunkar S; Zhang J; Yang J; Zhang H; Meka A; Yu C
    Chem Commun (Camb); 2014 May; 50(42):5547-50. PubMed ID: 24603852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-responsive controlled release of covalently bound prodrug from functional mesoporous silica nanospheres.
    Popat A; Ross BP; Liu J; Jambhrunkar S; Kleitz F; Qiao SZ
    Angew Chem Int Ed Engl; 2012 Dec; 51(50):12486-9. PubMed ID: 23129230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination drug release of smart cyclodextrin-gated mesoporous silica nanovehicles.
    Zhou S; Sha H; Ke X; Liu B; Wang X; Du X
    Chem Commun (Camb); 2015 Apr; 51(33):7203-6. PubMed ID: 25811958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
    Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
    J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
    Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
    Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugar and pH dual-responsive snap-top nanocarriers based on mesoporous silica-coated Fe3O4 magnetic nanoparticles for cargo delivery.
    Qiu XL; Li QL; Zhou Y; Jin XY; Qi AD; Yang YW
    Chem Commun (Camb); 2015 Mar; 51(20):4237-40. PubMed ID: 25670321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
    Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
    Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-cargo selectively controlled release based on a pH-responsive mesoporous silica system.
    Gui W; Wang W; Jiao X; Chen L; Wen Y; Zhang X
    Chemphyschem; 2015 Feb; 16(3):607-13. PubMed ID: 25492672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
    Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
    Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
    van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
    ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple way to obtain pH-sensitive drug release from functional mesoporous silica materials.
    Xiang D; Lin H; Guo W; Ma J; Cui L; Jiang J; Qu F
    IET Nanobiotechnol; 2014 Dec; 8(4):179-83. PubMed ID: 25429494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
    Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
    Liang C; Wang H; Zhang M; Cheng W; Li Z; Nie J; Liu G; Lian D; Xie Z; Huang L; Zeng X
    J Colloid Interface Sci; 2018 Sep; 525():1-10. PubMed ID: 29679795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esterase- and pH-responsive poly(β-amino ester)-capped mesoporous silica nanoparticles for drug delivery.
    Fernando IR; Ferris DP; Frasconi M; Malin D; Strekalova E; Yilmaz MD; Ambrogio MW; Algaradah MM; Hong MP; Chen X; Nassar MS; Botros YY; Cryns VL; Stoddart JF
    Nanoscale; 2015 Apr; 7(16):7178-83. PubMed ID: 25820516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pH-responsive nano-carrier with mesoporous silica nanoparticles cores and poly(acrylic acid) shell-layers: fabrication, characterization and properties for controlled release of salidroside.
    Peng H; Dong R; Wang S; Zhang Z; Luo M; Bai C; Zhao Q; Li J; Chen L; Xiong H
    Int J Pharm; 2013 Mar; 446(1-2):153-9. PubMed ID: 23395877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution.
    Baeza A; Manzano M; Colilla M; Vallet-Regí M
    Biomater Sci; 2016 May; 4(5):803-13. PubMed ID: 26902682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.